All News

Patients who used a medical beverage during chemotherapy treatment tended to have fewer gastrointestinal side effects and hospital visits, a small study showed.

Findings from a study demonstrated that patients may develop hypertension, or high blood pressure, as a result of treatment with Imbruvica for CLL, although it may be quickly managed without drug-drug interactions.

Many thoughts went through my mind during cancer, and journaling allowed me to organize them and helped me to feel better.

Olympic gymnast, Shannon Miller, sat down with CURE® to discuss her experience with a rare type of ovarian cancer, and how her competitive mindset helped her through.

I was experiencing a painful side effect from radiation therapy, but when the staff dressed up like characters from “The Wizard of Oz,” I became grateful for their willingness to brighten my day.

When Mary Colasuonno, B.S.N., RN, BMTCN, set her first career goal, it was about as far from nursing as it could be: She wanted to be a commercial artist.

While certain gut microbiota may affect how a patient with lymphoma may response to CAR-T cell therapy, far more work is needed to better understand the connection.

Mixed in the boxes of appointments and cancer treatments are milestones that uplift my spirits and are unique to my healing journey.

We recently asked patients, survivors and caregivers of those with cancer to share an inspiring quote or mantra that helped them through cancer.

In her career as a nurse, Mary Colasuonno, B.S.N., RN, BMTCN, has always made a conscious effort to make every interaction count.

Among patients who held ice in their mouth before, during and after chemotherapy, 78% did not experience oral mucositis.

Finding humor in cancer has helped me cope.

Erleada showed promising results in patients with metastatic castration-sensitive prostate cancer when compared with Xtandi and Zytiga.

A dose reduction of Erleada may result in fewer skin-related side effects for men with advanced prostate cancer — but only for those with a smaller body size, research showed.

Men with metastatic hormone-sensitive prostate cancer treated with Nubeqa, androgen-deprivation therapy and docetaxel had reductions in PSA levels that were associated with improved overall survival and a prolonged time to PSA progression.

May is National Melanoma and Skin Cancer Awareness Month, so we took a look at some of the top stories about the disease from 2023.

Even though my children are grown up, I still worry about their health — especially when it comes to breast cancer.

Extended-duration Nubeqa reduced the risk of death in patients with nonmetastatic castration-resistant prostate cancer, study results showed.

Patients with metastatic castration-resistant prostate cancer treated with radioligand therapy, a form of targeted therapy, had improvements in PSA levels and survival with favorable side effect profiles.

Dr. Naveen Pemmaraju outlines three reasons why he feels that there is “a momentum that’s unmistakable,” in the field of myeloproliferative neoplasms.

An interview with Kerry O’Neil, B.S.N., RN, OCN, finalist for the 2023 Extraordinary Healer® award.

In her 40 years as an oncology nurse and supervisor, Kerry O’Neil, B.S.N., RN, OCN, has eased the way for thousands of patients with cancer and their families

Watch Dr. Brandon J Blue, Dr. Surbhi Sidana, Dr. Kenneth H. Shain and Mary Derome answer questions about the future of treatment during the CURE Educated Patient Multiple Myeloma Summit.

An interview with Abbey Kaler, M.S., APRN, FNP-C, CMSRN, winner of the 2023 Extraordinary Healer® award.

Oncology nurse, Abbey Kaler, M.S., APRN, FNP-C, CMSRN daily follows the motto “Love, Listen and Heal.”

People are functioning as if the threat of COVID-19 is gone, but that’s not the case for many people with cancer.

From talk show host Jerry Springer’s death to “The Young and the Restless” star announcing a cancer diagnosis, here is what’s happening in the oncology space this week.

Watch Dr. Kenneth H. Shain, from Moffitt Cancer Center, discuss the future of myeloma treatment, including BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.